THE SHERWIN-WILLIAMS COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 279.2 EUR | -0.05% |
|
+0.72% | -0.91% |
| 06-12 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377, Maintains Outperform Rating | MT |
| 06-12 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377 | MT |
Strengths
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With an expected P/E ratio at 28.53 and 24.94 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.65 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.91% | 76.41B | - | ||
| -15.03% | 33.18B | B- | ||
| -14.02% | 30.27B | A- | ||
| -7.28% | 15.56B | B | ||
| -0.21% | 14.34B | B+ | ||
| -22.96% | 10.51B | B+ | ||
| +1.85% | 7.63B | B- | ||
| -16.93% | 7B | B | ||
| +5.87% | 3.34B | B- | ||
| -17.58% | 2.85B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SHW Stock
- SHWW Stock
- Ratings The Sherwin-Williams Company
